World map with illuminated lines and graphs on a dark background

Sell Summit Healthcare REIT Shares

Explore potential liquidity options for Summit Healthcare REIT shares, including current financial condition, valuation considerations, transferability, and secondary market alternatives.

REQUEST A CONFIDENTIAL REVIEW HOW IT WORKS

Investment Overview

Summit Healthcare REIT

Summit Healthcare REIT, Inc. is a non-traded real estate investment trust focused on senior housing and healthcare real estate. Its portfolio includes directly owned properties, consolidated joint-venture interests, and an equity-method investment in additional healthcare properties.

Summit's common shares are not listed on a national securities exchange. Investors seeking liquidity therefore cannot rely on a traditional public trading market and may need to evaluate transferability, current company liquidity policies, investment fundamentals, and potential secondary market alternatives.

As of June 30, 2026, Summit reported ownership interests in seven senior housing properties, including three wholly owned properties and four properties held through a consolidated joint venture, as well as a 10% interest in an unconsolidated investment holding five additional properties.


Investment Snapshot

Summit Healthcare REIT At A Glance

Investment Type

Non-Traded REIT

Primary Focus

Senior Housing & Healthcare Real Estate

Public Trading Market

None

Shares Outstanding

23,027,978

Cash & Cash Equivalents

$22.7 Million*

2026 Common Distributions

None Through June 30*

*Based on Summit Healthcare REIT's Form 10-Q for the quarter ended June 30, 2026.


Current Financial Position

Summit's 2026 Financial Condition

For the quarter ended June 30, 2026, Summit reported approximately $67.4 million in total assets and approximately $43.6 million in total liabilities, including approximately $39.3 million of loans payable net of debt issuance costs.

The company reported approximately $22.7 million of cash and cash equivalents as of June 30, 2026 and stated that, based on current conditions, it believed it had sufficient capital resources to sustain operations for more than twelve months from the filing date.

For the six months ended June 30, 2026, Summit reported a net loss applicable to common stockholders of approximately $1.38 million and funds from operations applicable to common stockholders of approximately negative $673,000.

These financial measures are relevant to evaluating an illiquid position, but they do not by themselves establish the price at which Summit shares may transact in a secondary market.


Portfolio

Senior Housing And Healthcare Real Estate

Summit describes its business as investing in senior housing facilities, including independent living, skilled nursing, assisted living, memory care, and continuing care retirement communities.

As of June 30, 2026, the company reported direct and joint-venture interests across a smaller portfolio than in earlier periods. Summit has also stated that its growth depends in part on its ability to raise joint-venture or other equity, acquire healthcare properties at attractive prices, negotiate sustainable tenant leases, and control operating expenses.

Changes in portfolio composition, property sales, joint-venture interests, occupancy, operator performance, and the company's capital structure may all affect how prospective buyers evaluate Summit shares.


Distributions

Recent Summit Healthcare REIT Distributions

Summit declared a cash dividend of $0.045 per share in April 2025, totaling approximately $1.0 million. According to the company's June 30, 2026 Form 10-Q, no common-stock distributions were declared or paid during the first six months of 2026.

Distribution history is one factor secondary-market participants may consider when evaluating an illiquid REIT position. A change in distributions does not necessarily determine the value of the shares, but it can affect investor expectations and buyer demand.


Secondary Market

Can Summit Healthcare REIT Shares Be Sold?

Potentially. Because Summit Healthcare REIT shares are not traded on a national securities exchange, shareholders generally cannot sell through a conventional public brokerage market.

A potential privately negotiated or secondary market transaction may depend on the shareholder's position size, ownership structure, available documentation, transfer restrictions, buyer qualifications, current company fundamentals, and prevailing buyer demand.

Investors can learn more about selling non-traded REIT shares, review how the secondary market for non-traded REITs works, or read AIL's guide on how to sell a non-traded REIT.


Valuation Considerations

Understanding Summit Healthcare REIT Share Value

Estimated Values

Summit has historically calculated estimated per-share values using estimated real estate and other asset values, less liabilities, while applying adjustments related to the absence of a national exchange trading market and lack of a control premium.

An estimated value is a reference point and should not automatically be interpreted as the price available in a current secondary market transaction.

Financial Condition

Portfolio performance, cash resources, debt obligations, operating results, property transactions, litigation costs, and joint-venture performance may influence how buyers assess the investment.

Secondary Market Value

A potential secondary market price may be higher or lower than values shown in sponsor materials, account statements, financial reports, or prior transactions. Actual marketability depends on the terms available from qualified purchasers at the time a shareholder seeks liquidity.


Marketability

Factors That May Affect Summit Share Liquidity

Absence Of Exchange Trading

Summit shares are not listed on a national securities exchange, limiting the availability of continuous market pricing and public-market liquidity.

Portfolio Performance

Senior housing occupancy, resident revenue, property operating costs, operator performance, and asset dispositions can influence investor perceptions of value.

Debt And Capital Structure

As of June 30, 2026, Summit reported approximately $40.8 million of debt obligations, primarily long-term fixed-rate HUD-insured loans with maturities extending from 2039 through 2055.

Company Liquidity

Summit reported approximately $22.7 million of cash and cash equivalents as of June 30, 2026 and identified rental revenues and equity-method investment distributions as expected primary sources of cash.

Position Size And Buyer Demand

The number of shares offered, account registration, transfer requirements, and the availability of qualified buyers can affect the terms and timing of a potential transaction.


Documentation

Information Commonly Requested For Review

A recent account statement is generally the most useful starting point when evaluating a Summit Healthcare REIT position.

The statement can help confirm the number of shares, ownership registration, account type, custodian, and how the investment is currently reported. Additional records may be requested depending on whether the position is held individually, in an IRA, trust, estate, partnership, LLC, or other entity.


Confidential Investment Review

Evaluating A Potential Summit Healthcare REIT Liquidity Pathway

Alternative Investment Liquidity reviews Summit Healthcare REIT positions on a case-by-case basis to determine whether a potential secondary market liquidity opportunity may exist.

The review may consider position size, ownership structure, available documentation, transferability, current company fundamentals, distributions, debt, portfolio composition, and prevailing secondary market demand.

Requesting a review does not obligate an investor to sell. If a potential liquidity pathway is identified, AIL can discuss proposed terms, documentation requirements, transfer procedures, timing, and next steps before the shareholder decides whether to proceed.

Request a Confidential Investment Review.


Important Considerations

Reported Values And Secondary Market Prices Are Different

Financial statement values, estimated per-share values, account statement values, historical transaction prices, and potential secondary market offers represent different measures and should not be treated as interchangeable.

AIL is not affiliated with Summit Healthcare REIT, Inc. Any potential secondary market transaction evaluated by AIL would be considered independently based on the specific shareholder position and then-current market conditions.

EVALUATION CRITERIA

Every Opportunity
Is Reviewed Individually

Every Opportunity
Is Reviewed

Secondary market interest depends on more than asset type. AIL evaluates each position based on investment structure, transferability, documentation, and current market conditions.

Investment Structure

Ownership type, sponsor requirements, investment terms, and underlying asset characteristics all influence review.

Transferability

Some positions may be subject to transfer restrictions, approval requirements, or limitations within governing documents.

Documentation

Offering materials, account records, ownership documents, and sponsor information help determine whether review can proceed.

Market Demand

Potential liquidity depends on current buyer interest, asset category, pricing expectations, and transaction feasibility.

THE REVIEW PROCESS

A Structured Review
Without Obligation

Every opportunity is reviewed individually. Our process is designed to provide clarity regarding transferability, marketability, and potential liquidity pathways before any transaction decisions are made.

01

Submit Information

Provide basic details regarding the investment position, ownership structure, and available documentation.

02

Review

AIL evaluates the investment type, transfer restrictions, sponsor requirements, and available transfer pathways.

03

Market Assessment

We determine whether a secondary market opportunity may exist based on current investor demand and transaction activity.

04

Discuss Options

If a viable pathway exists, we discuss potential next steps, timing considerations, and transaction requirements.

Summit Healthcare REIT
Liquidity FAQ

Can I sell my Summit Healthcare REIT shares?

Potentially. Summit Healthcare REIT shares are not traded on a national securities exchange, so liquidity may depend on transfer requirements, ownership structure, available documentation, buyer qualifications, and current secondary market demand.

Is Summit Healthcare REIT publicly traded?

No. Summit Healthcare REIT reported that its common shares are not registered for trading on a national securities exchange. This means shareholders do not have the same continuous public-market liquidity available with an exchange-listed REIT.

What is the current financial condition of Summit Healthcare REIT?

As of June 30, 2026, Summit reported approximately $67.4 million in total assets, $43.6 million in total liabilities, and $22.7 million in cash and cash equivalents. The company also reported a net loss applicable to common stockholders of approximately $1.38 million for the first six months of 2026.

Is Summit Healthcare REIT currently paying distributions?

Summit reported that no common-stock distributions were declared or paid during the six months ended June 30, 2026. The company had previously declared a $0.045 per-share cash dividend in April 2025.

How is the value of Summit Healthcare REIT shares determined?

Estimated values, account statement values, and potential secondary market transaction prices are different measures. A secondary market value may reflect portfolio performance, debt, distributions, transferability, position size, buyer demand, and current market conditions..

What information does AIL need to review my Summit Healthcare REIT position?

An initial Confidential Investment Review generally begins with a recent account statement showing the Summit Healthcare REIT position, number of shares, and ownership or account type. Additional documents may be requested depending on the position and transfer requirements.

CONFIDENTIAL A REVIEW

Ready To Request
A Confidential Review?

Submit basic information for a confidential review. Opportunities are evaluated individually based on investment structure, available documentation, transferability, and potential market interest.

REQUEST A CONFIDENTIAL REVIEW